• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Avoiding Catastrophe: Understanding Free Light Chain Testing in the Evaluation of ATTR Amyloidosis.

作者信息

Witteles Ronald M, Liedtke Michaela

机构信息

Stanford Amyloid Center, Stanford, CA (R.M.W., M.L.).

Division of Cardiovascular Medicine (R.M.W.), Stanford University School of Medicine, CA.

出版信息

Circ Heart Fail. 2021 Apr;14(4):e008225. doi: 10.1161/CIRCHEARTFAILURE.120.008225. Epub 2021 Mar 19.

DOI:10.1161/CIRCHEARTFAILURE.120.008225
PMID:33736459
Abstract
摘要

相似文献

1
Avoiding Catastrophe: Understanding Free Light Chain Testing in the Evaluation of ATTR Amyloidosis.避免灾难：了解游离轻链检测在转甲状腺素蛋白淀粉样变性评估中的应用
Circ Heart Fail. 2021 Apr;14(4):e008225. doi: 10.1161/CIRCHEARTFAILURE.120.008225. Epub 2021 Mar 19.
2
Validation of Mayo Clinic Staging System for Light Chain Amyloidosis With High-Sensitivity Troponin.基于高敏肌钙蛋白的梅奥诊所轻链淀粉样变性分期系统的验证
J Clin Oncol. 2019 Jan 10;37(2):171-173. doi: 10.1200/JCO.18.01398. Epub 2018 Nov 15.
3
Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.心脏淀粉样变性的诊断：关于影像学和生物标志物作用的系统评价
BMC Cardiovasc Disord. 2018 Dec 4;18(1):221. doi: 10.1186/s12872-018-0952-8.
4
Myocardial Amyloidosis: The Exemplar Interstitial Disease.心肌淀粉样变性：典型的间质性疾病。
JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 2):2345-2356. doi: 10.1016/j.jcmg.2019.06.023. Epub 2019 Aug 14.
5
Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio.利用治疗结束时受累游离轻链水平优化AL淀粉样变性的深度缓解评估：血清游离轻链比值的不足
Leukemia. 2019 Feb;33(2):527-531. doi: 10.1038/s41375-018-0258-y. Epub 2018 Sep 26.
6
Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.二维斑点追踪超声心动图对左心室射血分数保留型轻链型淀粉样变性患者预后的评估：对现行预后分期系统的补充价值。
JACC Cardiovasc Imaging. 2017 Apr;10(4):398-407. doi: 10.1016/j.jcmg.2016.04.008. Epub 2016 Sep 14.
7
Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters.原发性系统性轻链淀粉样变患者心脏受累和生存的预测因素：临床、化学和三维斑点追踪超声心动图参数的作用。
BMC Cardiovasc Disord. 2021 Jan 21;21(1):43. doi: 10.1186/s12872-021-01856-3.
8
Early Phase Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac Amyloidosis.早期Tc-HMDP心肌灌注显像在心脏淀粉样变性诊断及分型中的应用
JACC Cardiovasc Imaging. 2017 May;10(5):601-603. doi: 10.1016/j.jcmg.2016.05.007. Epub 2016 Jul 13.
9
A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis.一种用于鉴定系统性轻链淀粉样变性中血清单克隆轻链成分的新型质谱方法。
Blood Cancer J. 2019 Feb 4;9(2):16. doi: 10.1038/s41408-019-0180-1.
10
Diagnostic accuracy of new indirect ELISAs for free light-chain quantification in fat tissue of patients with AL amyloidosis.新型间接酶联免疫吸附测定法对AL淀粉样变性患者脂肪组织中游离轻链定量的诊断准确性
Amyloid. 2017 Mar;24(sup1):46-47. doi: 10.1080/13506129.2017.1284058.

引用本文的文献

1
Disease-modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications.转甲状腺素蛋白淀粉样变心肌病的疾病修饰疗法：现有及新兴药物
Pharmacotherapy. 2025 Feb;45(2):124-144. doi: 10.1002/phar.4639. Epub 2024 Dec 23.
2
Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic Advances.心脏淀粉样变的治疗策略进展：从发病机制的发现到诊断和治疗的进步。
Cardiol Clin. 2025 Feb;43(1):93-110. doi: 10.1016/j.ccl.2024.09.006. Epub 2024 Oct 22.
3
Effect of Timely Availability of TTR-Stabilizing Therapy on Diagnosis, Therapy, and Clinical Outcomes in ATTR-CM.
转甲状腺素蛋白稳定疗法的及时可及性对甲状腺转运蛋白淀粉样变心肌病的诊断、治疗及临床结局的影响
J Clin Med. 2024 Sep 6;13(17):5291. doi: 10.3390/jcm13175291.
4
Recent advances in the diagnostic methods and therapeutic strategies of transthyretin cardiac amyloidosis.转甲状腺素蛋白心脏淀粉样变的诊断方法与治疗策略的最新进展
World J Cardiol. 2024 Jul 26;16(7):370-379. doi: 10.4330/wjc.v16.i7.370.
5
World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM).世界心脏联合会关于转甲状腺素蛋白淀粉样变性心肌病（ATTR-CM）的共识。
Glob Heart. 2023 Oct 26;18(1):59. doi: 10.5334/gh.1262. eCollection 2023.
6
Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.老年主动脉瓣狭窄行经导管主动脉瓣置换术患者的转甲状腺素蛋白淀粉样变心肌病。
J Am Heart Assoc. 2023 Aug 15;12(16):e030271. doi: 10.1161/JAHA.123.030271. Epub 2023 Aug 10.
7
Light-chain cardiac amyloidosis for the non-expert: pearls and pitfalls.非专业人士的轻链型心脏淀粉样变：要点和陷阱。
Intern Emerg Med. 2023 Oct;18(7):1879-1886. doi: 10.1007/s11739-023-03335-3. Epub 2023 Jun 20.
8
Expanding indications for non-biopsy diagnosis of transthyretin amyloid cardiomyopathy.转甲状腺素蛋白淀粉样变心肌病非活检诊断的适应症扩展
Eur Heart J. 2023 Jun 25;44(24):2199-2201. doi: 10.1093/eurheartj/ehad281.
9
Step-by-step typing for the accurate diagnosis of concurrent light chain and transthyretin cardiac amyloidosis.分步打字可准确诊断同时存在的轻链和转甲状腺素蛋白心脏淀粉样变性。
ESC Heart Fail. 2022 Apr;9(2):1474-1477. doi: 10.1002/ehf2.13773. Epub 2022 Jan 21.